1,031 companies
AQST
Aquestive Therapeutics Inc
aquestive therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives.
New Jersey
NASDAQ
ARLZ
Aralez Pharmaceuticals Inc.
British Columbia, Canada
NASDAQ
PETX
Aratana Therapeutics, Inc.
Aratana Therapeutics, Inc.
Kansas
NASDAQ
ARAV
Aravive Inc
versartis, inc.
Texas
NASDAQ
ABUS
Arbutus Biopharma Corp
arbutus biopharma corporation (nasdaq:abus) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis b infection, a disease of the liver caused by hepatitis b virus (hbv). we are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the hbv treatment landscape and cure hepatitis b virus disease.
Pennsylvania
NASDAQ
ARCT
Arcturus Therapeutics Holdings Inc
founded in 2013 and based in san diego, calif., arcturus therapeutics is poised to become an industry leader in the application of rnai technologies for the treatment of disease and improved quality of life.
California
NASDAQ
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc.
California
RCUS
Arcus Biosciences Inc
arcus biosciences is an exciting young company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology.
California
NYSE
ARQT
Arcutis Biotherapeutics Inc
arcutis biotherapeutics, inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
California
NASDAQ
ARDX
Ardelyx Inc
ardelyx is focused on enhancing the way people with renal diseases are treated by developing first-in-class medicines.
California
NASDAQ
ARNA
Arena Pharmaceuticals Inc
Arena Pharmaceuticals, Inc.
California
NASDAQ
ARGS
Argos Therapeutics Inc
The ADAPT trial is a randomized, multicenter, open label trial comparing combination therapy with rocapuldencel-T and sunitinib (or another targeted therapy) to monotherapy with sunitinib (or another targeted therapy) for the treatment of newly diagnosed metastatic renal cell carcinoma (mRCC). A total of 462 previously untreated patients were enrolled in the ADAPT trial and randomized 2:1 between combination treatment with rocapuldencel-T and sunitinib (combination arm) vs.
North Carolina
NASDAQ
ARDS
Aridis Pharmaceuticals, Inc.
aridis is a privately held infectious diseases focused company in san jose, ca, usa.
California
NASDAQ
ARQL
Arqule Inc
We are a biopharmaceutical company engaged in the research and development of innovative therapeutics to treat cancers and rare diseases.
Massachusetts
NASDAQ
Array Technologies Inc
We are a fully-integrated, biopharmaceutical company focused on the discovery, development and commercialization of transformative and well-tolerated targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases.
Colorado
AVBP
ArriVent BioPharma Inc.
Pennsylvania
NASDAQ
ARWR
Arrowhead Pharmaceuticals Inc.
arrowhead pharmaceuticals is a clinical stage, nasdaq listed (ticker arwr) company developing medicines that treat intractable diseases by silencing the genes that cause them.
California
NASDAQ
ARTL
Artelo Biosciences Inc
artelo biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics.
California
NASDAQ
ARVN
Arvinas Inc
arvinas is a pharmaceutical company focused on developing new small molecules ‒ known as protacs (proteolysis targeting chimeras) ‒ aimed at degrading disease-causing cellular proteins via proteolysis.
Connecticut
NASDAQ
ASND
Ascendis Pharma A/S
ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.
Denmark
NASDAQ